Cargando…

Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice

Prior work has shown that parenterally administered anti-CD20 (5D2) inhibits CD4(+) T cell priming in response to challenge with Pneumocystis murina and predisposes to pneumonia. In this study, we investigated the effect of subcutaneous anti-CD20 antibody and Pneumocystis infection. In mice with pri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Guixiang, Noell, Kristin, Weckbecker, Gisbert, Kolls, Jay K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103991/ https://www.ncbi.nlm.nih.gov/pubmed/33952667 http://dx.doi.org/10.1128/mSphere.01144-20

Ejemplares similares

Germline IgM predicts T cell immunity to Pneumocystis
por: Noell, Kristin, et al.
Publicado: (2022)

Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice
por: Migotto, Mary-Anne, et al.
Publicado: (2019)

Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration
por: Torres, Julia Baguña, et al.
Publicado: (2022)

Toward a humanized mouse model of Pneumocystis pneumonia
por: Dai, Guixiang, et al.
Publicado: (2021)

B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
por: Leandro, Maria J
Publicado: (2013)

Novel Pneumocystis Antigens for Seroprevalence Studies
por: Pungan, Dora, et al.
Publicado: (2023)

Further Defining the Human Virome using NGS: Identification of Redondoviridae
por: Noell, Kristin, et al.
Publicado: (2019)

Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
por: Rouzière, Anne-Sophie, et al.
Publicado: (2005)

Can Systemic Anti-CD20 B Cell-Depleting Antibodies Eliminate Meningeal Follicles in Multiple Sclerosis?
por: Gupta, Sasha, et al.
Publicado: (2021)

Maintained partial protection against Streptococcus pneumoniae despite B‐cell depletion in mice vaccinated with a pneumococcal glycoconjugate vaccine
por: Ercoli, Giuseppe, et al.
Publicado: (2021)

A protracted course of Pneumocystis pneumonia in the setting of an immunosuppressed child with GMS-negative bronchoalveolar lavage
por: Eddens, Taylor, et al.
Publicado: (2016)

Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina
por: Rapaka, Rekha R., et al.
Publicado: (2010)

Resolution of Pneumocystis carinii pneumonia in CD4+ lymphocyte- depleted mice given aerosols of heat-treated Escherichia coli
Publicado: (1992)

Transcriptomic and Proteomic Approaches to Finding Novel Diagnostic and Immunogenic Candidates in Pneumocystis
por: Eddens, Taylor, et al.
Publicado: (2019)

Subcutaneous versus Intravenous Administration of Rituximab: Pharmacokinetics, CD20 Target Coverage and B-Cell Depletion in Cynomolgus Monkeys
por: Mao, Cheng-Ping, et al.
Publicado: (2013)

Frequency of Regulatory T Cells is Not Affected by Transient B Cell Depletion Using Anti-CD20 Antibodies in Rheumatoid Arthritis
por: Feuchtenberger, Martin, et al.
Publicado: (2008)

Anti-CD20 therapy depletes activated myelin-specific CD8(+) T cells in multiple sclerosis
por: Sabatino, Joseph J., et al.
Publicado: (2019)

The effect of B-cell depletion with an anti-CD20 antibody on the immunoglobulin heavy-chain repertoire in a patient with rheumatoid arthritis
por: Rouzière, A-S, et al.
Publicado: (2005)

Targeted NGS-Based Analysis of Pneumocystis jirovecii Reveals Novel Genotypes
por: Pungan, Dora, et al.
Publicado: (2022)

Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study
por: Fluge, Øystein, et al.
Publicado: (2011)

Antibody Response to Pneumocystis jirovecii: Antibody Response to Pneumocystis jirovecii Major Surface Glycoprotein
por: Daly, Kieran R., et al.
Publicado: (2006)

Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
por: Lehmann-Horn, Klaus, et al.
Publicado: (2011)

Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity
por: Lehmann-Horn, Klaus, et al.
Publicado: (2014)

COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseases
por: Baker, D., et al.
Publicado: (2020)

A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
por: Eisenberg, R, et al.
Publicado: (2003)

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
por: Fluge, Øystein, et al.
Publicado: (2009)

Case Report: Successful treatment of severe pneumocystis carinii pneumonia in a case series of primary nephrotic syndrome after receiving anti-CD20 monoclonal antibody therapy
por: Liu, Lili, et al.
Publicado: (2023)

The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to Streptococcus pneumoniae
por: Ercoli, Giuseppe, et al.
Publicado: (2021)

The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
por: Uchida, Junji, et al.
Publicado: (2004)

Surface Levels of CD20 Determine Anti-CD20 Antibodies Mediated Cell Death In Vitro
por: Singh, Vijay, et al.
Publicado: (2014)

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome
por: Lunde, Sigrid, et al.
Publicado: (2016)

Ocrelizumab Depletes CD20(+) T Cells in Multiple Sclerosis Patients
por: Gingele, Stefan, et al.
Publicado: (2018)

Ofatumumab: a novel monoclonal anti-CD20 antibody
por: Lin, Thomas S
Publicado: (2010)

Anti-CD20 monoclonal antibodies: reviewing a revolution
por: Casan, J. M. L., et al.
Publicado: (2018)

CD4 T-Cell Immunity in the Lung
por: Kolls, Jay K.
Publicado: (2012)

Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice
por: Kolomansky, Albert, et al.
Publicado: (2020)

Anti-CD8 monoclonal antibody-mediated depletion alters the phenotype and behavior of surviving CD8+ T cells
por: Cross, Eric W., et al.
Publicado: (2019)

B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4(+) T cell responses in highly sensitized transplant recipients
por: Tanaka, Asuka, et al.
Publicado: (2021)

Anti-CD25 Treatment Depletes Treg Cells and Decreases Disease Severity in Susceptible and Resistant Mice Infected with Paracoccidioides brasiliensis
por: Felonato, Maíra, et al.
Publicado: (2012)

CD4(+) T‐cell subsets and host defense in the lung
por: Kolls, Jay K.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tvbtuq3evvtedck8r03vaj1qrh